Neuro-Oncology Clinical Trials

Where You Are:

Clinical Trials Relating to the Brain and Nervous System as of 7/15/2014

Director Clinical Trials – Dr. Solmaz Sahebjam

Contact Information: Allie Drew 813-745-3229

MCC 15004 Southeastern Study of Cancer and the Environment


MCC 16110 A Prospective, Multicenter Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed Glioblastoma

MCC 17164 Phase 1B, Multi-Center, Open Label, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

MCC 17440 A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme (GBM)

MCC 17697 A Randomized Study of Nivolumab or Nivolumab Combined With Ipilimumab Vs Bevacizumab in Adult Subjects With Recurrent Glioblastoma (GBM) (CheckMate 143)

MCC 17829 Phase 2 Dose-Escalation Study of TPI 287 in Combination with Bevacizumab in Adults with Recurrent or Progressive Glioblastoma Following a Bevacizumab-Containing Regimen

Primary Central Nervous System Lymphema

MCC 16983 Phase II Randomized Study of Rituximab, Methotrexate, Procarbazine, Vincristine, and Cytarabine With and Without Low-Dose Whole-Brain Radiotherapy for Primary Central Nervous System Lymphoma

MCC 17868 A Randomized Phase II Trial of Myeloablative VS Non-Myeloablative Consolidation Chemotherapy For Newly Diagnosed Primary CNS B-Cell Lymphoma


MCC 17380 Phase III, Multi-Center, Open Label, Randomized, Controlled Study of the Efficacy and Safety of Oral LDE225 Vs Temozolomide in Patients With Hh-Pathway Activated Relapsed Medulloblastoma

TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions